When compared to the broader category of peptides versus SARMs , AOD 9604 sits firmly on the safer end of the spectrum
La Revue de medecine interne 2022
10.1038/nrneurol.2016.150 10 FaustinoL
Pemvidutide is also undergoing phase 2 studies as MASH treatment
Noland RC, Koves TR, Seiler SE, Lum H, Lust RM, Ilkayeva O, Stevens RD, Hegardt FG, Muoio DM: Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control
Community protocols on TRT describe: 1-2 mg subcutaneous daily (FDA-approved dose: 2 mg) 6-12 month protocols for visceral fat reduction Monitoring waist circumference, fasting glucose, and IGF-1 For men tracking their body composition changes on TRT, adding tesamorelin can accelerate the visceral fat reduction that typically takes 6-12 months on testosterone alone